BASF’s Nutrition & Health division is strengthening its position as ingredients partner for the animal nutrition and human nutrition industries by combining the strategic and operational responsibility in one global business unit, Nutrition Ingredients. In doing so, the focus will be on leveraging and further strengthening core product platforms and assets for vitamins and carotenoids that are deeply rooted into the BASF Verbund as well as expanding the business with feed enzymes.

In 2021, BASF completed an investment in a vitamin A plant expansion in Ludwigshafen, Germany to enhance vitamin A supply and will now expand its world-scale vitamin A formulation plant for animal nutrition with start-up scheduled in mid-2023. Moreover, in January 2022, BASF has expanded the production capacity of its feed enzymes plant in Ludwigshafen, which will further support the growth plans of customers in the animal nutrition industry.

For Aroma Ingredients, the organization will be further developed to support growth opportunities and investments, address sustainability trends and leverage proximity to growth markets.

“We have a leading position as a strong partner in nutrition, flavor, fragrance and pharma markets. We need to evolve by tailoring our business portfolio with growth investments into our core value chains, technology and R&D capabilities to meet sustainability needs and address the challenges of climate change,” said Anup Kothari, President, Nutrition & Health.

The new Nutrition Ingredients global business unit based in Germany will build on large-scale product platforms supported by the division’s technology leadership and will be led by Senior Vice President Julia Raquet.

BASF will continue to serve its customers in animal nutrition and human nutrition with dedicated teams. Beyond vitamins and carotenoids, feed enzymes will focus on high-quality ingredients to support animal nutrition customers in maximizing the nutritional value of feed.

Pharma Solutions will continue to be based in the United States and be led by Senior Vice President Jeffrey DeAlmeida. BASF will support customers in developing effective and reliable formulations with high-quality biopharmaceuticals, excipients, active ingredients and tailored digital solutions.